University of Virginia Health System

ALLOSOURCE ANNOUNCES FIRST IMPLANT OF ACECONNEX™ PRE-SUTURED FASCIA DEVICE IN HIP LABRAL RECONSTRUCTION PROCEDURE

Retrieved on: 
Wednesday, November 8, 2023
University of Virginia Health System, Allotransplantation, Anatomy, University, Surgeon, Patient, Sports medicine, Silk, Dentistry

CENTENNIAL, Colo., Nov. 8, 2023 /PRNewswire/ -- AlloSource®, one of the largest allograft providers creating innovative tissue products to help surgeons heal their patients, today announced the first implant of AceConnex Pre-Sutured Fascia device for hip labral reconstruction and augmentation. The labral reconstruction procedure was conducted by Dr. Winston Gwathmey at University of Virginia Health as part of AceConnex's limited market release, and marks the next step in the advancement of AlloSource's products to support hip arthroscopy. 

Key Points: 
  • CENTENNIAL, Colo., Nov. 8, 2023 /PRNewswire/ -- AlloSource®, one of the largest allograft providers creating innovative tissue products to help surgeons heal their patients, today announced the first implant of AceConnex Pre-Sutured Fascia device for hip labral reconstruction and augmentation.
  • "I appreciated having AceConnex Pre-Sutured Fascia for this labral reconstruction procedure because it made my process in the operating room more efficient versus the extra time suturing myself," said Dr. Gwathmey
    "I appreciated having AceConnex Pre-Sutured Fascia for this labral reconstruction procedure because it made my process in the operating room more efficient versus the extra time suturing myself," said Dr. Gwathmey.
  • For years, fascia allografts have been documented as an effective allograft for labral reconstruction.
  • 1,2
    "The AceConnex Pre-Sutured Fascia allograft device represents a commitment to developing patient specific solutions to treat hip labral injuries as part of our comprehensive sports medicine and hip arthroscopy portfolio," said Kevin Whitten, AlloSource Chief Commercial Officer.

Trisol announces successful implants of its Transcatheter Tricuspid Valve in the US

Retrieved on: 
Wednesday, August 23, 2023
University of Virginia Health System, University, TR, Food and Drug Administration, Cardiopulmonary bypass, Risk, Valvular heart disease, EFS, Principal, Food, Medical device, Trisol, MD

YOKNEAM, Israel, Aug. 23, 2023 /PRNewswire/ -- The heart teams at the Piedmont Heart Institute in Atlanta, Georgia, USA and the University of Virginia Health System in Charlottesville, VA, USA, successfully performed the first two implantations in the US of the Trisol Transcatheter Tricuspid Valve Replacement as part of a U.S. Food and Drug Administration approved Early Feasibility Study (EFS), led by Principal Investigator Isaac George, MD.

Key Points: 
  • We were able to abolish the patient's valvular heart disease via a minimally invasive procedure without the need for cardiopulmonary bypass.
  • Trisol patented valve features a distinctive design, that sets it apart from other tricuspid valves technologies.
  • Trisol valve is comprised of a single leaflet, the leaflet is affixed by 2 commissures enabling it to function as a bi-leaflet valve.
  • Five of these implants were performed as part of the Israeli Pilot Study, led by Principal Investigator Ran Kornowski, MD.

Trisol announces successful implants of its Transcatheter Tricuspid Valve in the US

Retrieved on: 
Wednesday, August 23, 2023
University of Virginia Health System, University, TR, Food and Drug Administration, Cardiopulmonary bypass, Risk, Valvular heart disease, EFS, Principal, Food, Medical device, Trisol, MD

YOKNEAM, Israel, Aug. 23, 2023 /PRNewswire/ -- The heart teams at the Piedmont Heart Institute in Atlanta, Georgia, USA and the University of Virginia Health System in Charlottesville, VA, USA, successfully performed the first two implantations in the US of the Trisol Transcatheter Tricuspid Valve Replacement as part of a U.S. Food and Drug Administration approved Early Feasibility Study (EFS), led by Principal Investigator Isaac George, MD.

Key Points: 
  • We were able to abolish the patient's valvular heart disease via a minimally invasive procedure without the need for cardiopulmonary bypass.
  • Trisol patented valve features a distinctive design, that sets it apart from other tricuspid valves technologies.
  • Trisol valve is comprised of a single leaflet, the leaflet is affixed by 2 commissures enabling it to function as a bi-leaflet valve.
  • Five of these implants were performed as part of the Israeli Pilot Study, led by Principal Investigator Ran Kornowski, MD.

Mental Health in the Spotlight as Three Employers Receive New Award for Exemplary Efforts to Support Workforce Wellbeing

Retrieved on: 
Wednesday, October 5, 2022
Well, Fair trade coffee, Culture, Associated Banc-Corp, Public health, Carolyn, Luv Puri, Education, Award, University of Virginia Health System, Johns Hopkins Bloomberg School of Public Health, Program, Multimedia, Mental health, Employee assistance program, University, Doctor of Philosophy, Health, Luv, General Electric, ISCB Senior Scientist Award, View, NIOSH, Medicine, Pharmaceutical industry, Workplace, MD, Memory

Akin Gump Strauss Hauer & Feld LLP , Metro Nashville Public Schools and the University of Virginia were recognized with the 2022 Mattingly Workplace Award for their comprehensive efforts to advance workforce mental health and psychological wellbeing.

Key Points: 
  • Akin Gump Strauss Hauer & Feld LLP , Metro Nashville Public Schools and the University of Virginia were recognized with the 2022 Mattingly Workplace Award for their comprehensive efforts to advance workforce mental health and psychological wellbeing.
  • "We know that workplace mental health efforts are most effective when they follow evidence-based practices and are embedded within a culture of health and wellbeing.
  • The Award recognizes and celebrates exemplary organizations that advance the mental health and wellbeing of their workers, thus serving as role models for other employers.
  • More information about the Carolyn C. Mattingly Award for Mental Health in the Workplace is available here .

Moximed to Unveil Data from Pivotal Study of MISHA™ Knee System for First Time at Orthopaedic Summit (OSET) 2022

Retrieved on: 
Thursday, September 15, 2022
Health, Medical Devices, Other Health, Knee, Sports medicine, University of Virginia Health System, Faculty, Anterior cruciate ligament injury, Walking, Trial of the century, Department, Hospital for Special Surgery, OSET, Hospital, Ohio State University, CME, University of Virginia, Orthopedic surgery, Osteoarthritis, Patient, Ohio State University Wexner Medical Center, Pain, Quality of life, Standard of care, Surgeon, Congress, Chitranjan Singh Ranawat, Doctor of Philosophy, Leadership, University, HSS, OA, Dentistry, Shipbuilding, MD

Voshell Professor of Sports Medicine, Department of Sports Medicine, University of Virginia, will present key data from the pivotal study of the MISHA Knee System at the 12th Orthopaedic Summit (OSET).

Key Points: 
  • Voshell Professor of Sports Medicine, Department of Sports Medicine, University of Virginia, will present key data from the pivotal study of the MISHA Knee System at the 12th Orthopaedic Summit (OSET).
  • The presentations will be part of a CME-accredited surgical congress and will be featured in a session on Knee Cartilage and Biologics.
  • Specifically, the faculty were asked to consider treatment options for a 43-year-old with moderate, but chronically painful, knee OA who wishes to remain physically active.
  • The companys technology, the MISHA Knee System, is the first implantable shock absorber for the treatment of medial compartment knee osteoarthritis (OA).

Amy Schutt, M.D. Joins Texas Fertility Center as a Reproductive Endocrinologist

Retrieved on: 
Tuesday, August 9, 2022
Baylor College of Medicine, University of Virginia Health System, Faculty, GLOBE, Polycystic ovary syndrome, Female, IVF, Infertility, Houstonia (magazine), LGBTQ, Professional, Baylor University, Research, Nursing, Texas Tech University School of Law, Patient, Reproductive medicine, Male, Southwestern United States, Fertility, Gynaecology, PCOS, Master of Science in Respiratory Care, REI, Physician, University, Fertility preservation, TFC, AOA, Birth control, Science, Obstetrics, Medicine, MSCI

According to Texas Fertility Center Medical Director Kaylen Silverberg, M.D., We have seen an increased demand for fertility treatment, and at Texas Fertility Center, we want to make sure we can provide care to everyone who seeks out our support.

Key Points: 
  • According to Texas Fertility Center Medical Director Kaylen Silverberg, M.D., We have seen an increased demand for fertility treatment, and at Texas Fertility Center, we want to make sure we can provide care to everyone who seeks out our support.
  • Amy Schutt, M.D., graduated from medical school at the Texas Tech University School of Medicine and was elected to AOA.
  • She is especially passionate about supporting patients with PCOS as well as providing LGBTQ fertility care and fertility preservation services, which are all services Texas Fertility Center offers.
  • Amy Schutt, M.D., is now accepting new patients at Texas Fertility Center.

Owens & Minor Breaks Ground on Center of Excellence for Medical Supply Logistics in West Virginia

Retrieved on: 
Monday, June 27, 2022
Practice Management, Other Manufacturing, Medical Supplies, General Health, Health, Logistics, Supply Chain Management, Transport, Manufacturing, Efficiency, University of Virginia Health System, Fortune 500, Patient, LinkedIn, CEO, OMI, Health system, WVU Medicine, Economic development, Personal protective equipment, PPE, Owens & Minor, National Association Medical Staff Services, University Health System, Partnership, NYSE, Solution, Twitter, Bed, Sterilization, Multimedia, Hospital, Medical device, Management

Owens & Minor, Inc. (NYSE: OMI), a leading global healthcare solutions company, today broke ground in Morgantown, West Virginia, on the future site of a center of excellence for medical supplies and logistics.

Key Points: 
  • Owens & Minor, Inc. (NYSE: OMI), a leading global healthcare solutions company, today broke ground in Morgantown, West Virginia, on the future site of a center of excellence for medical supplies and logistics.
  • Owens & Minor was joined for the groundbreaking by its local partner, West Virginia University Health System, which operates under the brand name WVU Medicine.
  • I applaud WVU Medicine and Owens & Minor and look forward to seeing even more of what this partnership brings to West Virginia.
  • The West Virginia University Health System is West Virginias largest health system and the states largest employer.

Shoulder Surgeons Perform First U.S. Surgeries Using Exactech’s Next Generation Cage Glenoid

Retrieved on: 
Tuesday, May 24, 2022
Medical Devices, Health, Surgery, Other Health, Clinical Trials, General Health, University of Virginia Health System, Physician, Hospital, Mayo Clinic, Surgeon, Body cavity, Multimedia, Patient, Arthropathy, Percussion section, Clinical professor, University, Titanium, Orthopedic surgery, YouTube, Instagram, Schoch, UHMWPE, LinkedIn, Twitter, 3D, Active, MD, Dentistry, Medical device, DRS, Pacific Ocean

View the full release here: https://www.businesswire.com/news/home/20220524005532/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220524005532/en/
    The Equinoxe Laser Cage Glenoid is an innovative, next-generation shoulder implant designed to improve glenoid fixation in anatomic total shoulder arthroplasty.
  • (Photo: Business Wire)
    This new glenoid implant, available in standard and augmented options, features a central bone cage and three peripheral cage pegs.
  • The Laser Cage Glenoid builds upon the foundation of the original cage glenoid design, which has been clinically available since 2011.
  • Clinical and Radiographic Comparison of a Hybrid Cage Glenoid to a Cemented Polyethylene Glenoid in Anatomic Total Shoulder Arthroplasty.

Healios AG Announces Addition of Anna Walz to Board of Directors

Retrieved on: 
Tuesday, April 12, 2022
News, Board, Entrepreneurship, MIT, CE marking, Massachusetts Institute of Technology, University Hospital of Basel, Multiple sclerosis, Dream, Research, MAPS, BYOD, Board of directors, Leadership, GLOBE, EMP, Patient, Biomarker, Bring your own device, Digital marketing, Founder, University of Virginia Health System, EHR, Medtech, Female, Consultant, Medical Affairs Bureau, FDA, MS, Health system, Medical device, Management, Medical imaging, EU, Neuroscience

BASEL, Switzerland, April 12, 2022 (GLOBE NEWSWIRE) -- Healios AG, a MedTech company focused on developing and validating digital biomarkers since 2014, announced that Anna Walz has been appointed to the company's Board of Directors.

Key Points: 
  • BASEL, Switzerland, April 12, 2022 (GLOBE NEWSWIRE) -- Healios AG, a MedTech company focused on developing and validating digital biomarkers since 2014, announced that Anna Walz has been appointed to the company's Board of Directors.
  • The Healios AG technology meets requirements for CE Mark and FDA and has applications across neuroscience, cardiovascular and beyond.
  • Additionally, Healios AG has the only system architecture that enables integrability with other platforms such as EHR and wearables.
  • Additional information about Healios AG can be obtained at www.healios.io .For press inquiries, contact [email protected] .

Brendon Stiles, MD, Joins LUNGevity Scientific Advisory Board

Retrieved on: 
Thursday, April 7, 2022
BUT, Health equity, Human, Public policy, Survivor, Cancer, Lung, Strathcona County, Montefiore Medical Center, Weill Cornell Medicine, Multimedia, Caregiver, University, Memorial Sloan Kettering Cancer Center, Prostate, Survival, Breast, Doctor of Philosophy, Faculty, Publication, Coronavirus Scientific Advisory Board (Turkey), General surgery, Associate, MPH, Memorial, Conference, Cardiothoracic surgery, Albert Einstein College of Medicine, Surgical oncology, University of Virginia Health System, Charity Navigator, Immune system, Quality of life, Lung cancer, Smoker, New, Helpline, Policy, Foundation, SAB, Clinical trial, Education, Patient, Pharmaceutical industry, Medical imaging, Research, MD

WASHINGTON, April 7, 2022 /PRNewswire/ -- LUNGevity Foundation extends its welcome to the foundation's newest Scientific Advisory Board member, Brendon Stiles, MD. Dr. Stiles was recently appointed Chief of Thoracic Surgery and Surgical Oncology at Montefiore Health System and Albert Einstein College of Medicine, and the Associate Director for Surgical Services in the Montefiore-Einstein Cancer Center. He brings over 20 years of career experience treating lung and esophageal cancer and has a clinical interest in unusual thoracic cancers, as well as benign chest and upper gastrointestinal diseases.

Key Points: 
  • A highly recognized cardiothoracic surgeon, Dr. Stiles is committed to eliminating health disparities
    WASHINGTON, April 7, 2022 /PRNewswire/ --LUNGevity Foundation extends its welcome to the foundation's newest Scientific Advisory Board member, Brendon Stiles, MD.
  • His clinical studies concentrate on managing early-stage or screen-detected lung cancer and novel multidisciplinary treatment strategies for patients with lung cancer.
  • In the laboratory, he investigates a protein called ART1 and its role in protecting cancer cells from the immune system.
  • "Brendon is a highly recognized expert in the field of lung, esophageal, and unusual thoracic cancers.